Exafib 20mg Tablet contains Rivaroxaban, an oral anticoagulant that belongs to the class of direct Factor Xa inhibitors. It is primarily prescribed to prevent and treat blood clots in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. By selectively inhibiting Factor Xa, Exafib prevents the conversion of prothrombin to thrombin, thereby reducing clot formation without affecting platelet aggregation. This mechanism allows for effective anticoagulation with a lower risk of bleeding compared to traditional anticoagulants like warfarin. Exafib offers the convenience of fixed dosing without the need for routine coagulation monitoring, making it suitable for long-term management. It is important to take Exafib exactly as prescribed, usually once daily with food to enhance absorption. Patients should inform their healthcare provider about any history of bleeding disorders, kidney or liver problems, or concurrent use of other medications that may increase bleeding risk. Common side effects may include bleeding, bruising, or gastrointestinal discomfort. Immediate medical attention is necessary if signs of serious bleeding occur. Exafib 20mg Tablet is a vital medication for managing thromboembolic disorders and improving patient outcomes.